Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.


Listen to the latest hemonc news from international experts

The Myeloma Sessions: key updates from ASH 2020

Over the last decades, a deeper understanding of multiple myeloma’s complex pathobiology has transformed the diagnosis, prognosis, and treatment paradigm, resulting in significant improvements in patient outcomes. Despite advances in treatment and outcomes, multiple myeloma is still considered an incurable disease. The management of newly diagnosed transplant-eligible patients and treatment approaches for relapsed/refractory myeloma remain hotly debated topics among the experts. The development of targeted and immune agents represents an important therapeutic strategy that can potentially translate into myeloma’s eventual cure.

In this exclusive podcast, MarĂ­a-Victoria Mateos, MD, PhD, University of Salamanca, Salamanca, Spain, Thomas Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, and Nina Shah, MD, University of California-San Francisco, San Francisco, CA, discuss the critical data presented at the ASH 2020 virtual Annual Meeting and how they might influence the treatment paradigm in myeloma.

Date: 22nd February 2021

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter